Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?
- PMID: 32646015
- PMCID: PMC7412566
- DOI: 10.3390/v12070735
Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?
Abstract
Standard precautions to minimize the risk of SARS-CoV-2 transmission implies that infected cell cultures and clinical specimens may undergo some sort of inactivation to reduce or abolish infectivity. We evaluated three heat inactivation protocols (56 °C-30 min, 60 °C-60 min and 92 °C-15 min) on SARS-CoV-2 using (i) infected cell culture supernatant, (ii) virus-spiked human sera (iii) and nasopharyngeal samples according to the recommendations of the European norm NF EN 14476-A2. Regardless of the protocol and the type of samples, a 4 Log10 TCID50 reduction was observed. However, samples containing viral loads > 6 Log10 TCID50 were still infectious after 56 °C-30 min and 60 °C-60 min, although infectivity was < 10 TCID50. The protocols 56 °C-30 min and 60 °C-60 min had little influence on the RNA copies detection, whereas 92 °C-15 min drastically reduced the limit of detection, which suggests that this protocol should be avoided for inactivation ahead of molecular diagnostics. Lastly, 56 °C-30 min treatment of serum specimens had a negligible influence on the results of IgG detection using a commercial ELISA test, whereas a drastic decrease in neutralizing titers was observed.
Keywords: COVID-19; ELISA; SARS-CoV-2; coronavirus; heat inactivation; neutralization; serology; virus neutralization test.
Conflict of interest statement
The authors declare no conflict of interest
Figures
References
-
- Otter J.A., Donskey C., Yezli S., Douthwaite S., Goldenberg S.D., Weber D.J. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: The possible role of dry surface contamination. J. Hosp. Infect. 2016;92:235–250. doi: 10.1016/j.jhin.2015.08.027. - DOI - PMC - PubMed
-
- Ong S.W.X., Tan Y.K., Chia P.Y., Lee T.H., Ng O.T., Wong M.S.Y., Marimuthu K. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA. 2020 doi: 10.1001/jama.2020.3227. - DOI - PMC - PubMed
-
- World Health Organization . Laboratory Biosafety Guidance Related to Coronavirus Disease 2019 ( COVID-19): Interim Guidance. WHO; Geneva, Switzerland: Feb 12, [(accessed on 12 February 2020)]. Available online: https://apps.who.int/iris/handle/10665/331138.
Publication types
MeSH terms
Substances
Grants and funding
- 871029/H2020 Research Infrastructures/International
- 101003544/H2020 European Institute of Innovation and Technology/International
- PREPMedVet/Agence Nationale de la Recherche/International
- IMI2 VHFMODRAD 823666/H2020 European Institute of Innovation and Technology/International
- REACTing/Institut National de la Santé et de la Recherche Médicale/International
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
